176 related articles for article (PubMed ID: 11857291)
1. Breast carcinoma in women age 25 years or less.
Kothari AS; Beechey-Newman N; D'Arrigo C; Hanby AM; Ryder K; Hamed H; Fentiman IS
Cancer; 2002 Feb; 94(3):606-14. PubMed ID: 11857291
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
4. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
6. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S
J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203
[TBL] [Abstract][Full Text] [Related]
7. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
[TBL] [Abstract][Full Text] [Related]
8. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
9. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
Dawson PJ; Ferguson DJ; Karrison T
Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
[TBL] [Abstract][Full Text] [Related]
10. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
[TBL] [Abstract][Full Text] [Related]
11. Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy?
Rosen PP; Kinne DW; Lesser M; Hellman S
Cancer; 1986 Apr; 57(7):1415-20. PubMed ID: 3004690
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype.
VandenBussche CJ; Elwood H; Cimino-Mathews A; Bittar Z; Illei PB; Warzecha HN
Hum Pathol; 2013 Nov; 44(11):2487-93. PubMed ID: 24029706
[TBL] [Abstract][Full Text] [Related]
14. Intraductal carcinoma of the breast: follow-up after biopsy only.
Page DL; Dupont WD; Rogers LW; Landenberger M
Cancer; 1982 Feb; 49(4):751-8. PubMed ID: 6275978
[TBL] [Abstract][Full Text] [Related]
15. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
[TBL] [Abstract][Full Text] [Related]
16. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
17. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 study.
Ozkaya Akagunduz O; Ergen A; Erpolat P; Gultekin M; Akkus Yildirim B; Parvizi M; Ikiz D; Colpan Oksuz D; Onal C; Yildiz F; Ozsaran Z
Breast; 2018 Dec; 42():10-14. PubMed ID: 30121548
[TBL] [Abstract][Full Text] [Related]
20. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
